Barclays Reinstates Emerson (EMR) at Equalweight
Tweet
Share
E-mailGet Alerts EMR Hot Sheet
Price: $163.17 -0.29%
Rating Summary:
26 Buy, 20 Hold, 2 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Rating Summary:
26 Buy, 20 Hold, 2 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Join SI Premium – FREE
Barclays analyst Julian Mitchell reinstates coverage on Emerson (NYSE: EMR) with a Equalweight rating and a price target of $105.00.
For an analyst ratings summary and ratings history on Emerson click here. For more ratings news on Emerson click here.
Shares of Emerson closed at $97.64 yesterday.
You May Also Be Interested In
- Emerson (EMR) PT Raised to $186 at Bernstein SocGen Group
- JPMorgan Assumes salesforce.com (CRM) at Overweight, 'Overblown Concerns'
- BofA Securities Resumes American Eagle Outfitters (AEO) at Underperform
Create E-mail Alert Related Categories
New CoverageSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
